[(2R)-2-[(3S,5S,8R,9S,10S,13R,14S,15R,17R)-3-[tert-butyl(dimethyl)silyl]oxy-15-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]propyl] acetate

C30H54O4Si — CID 100995819

IUPAC[(2R)-2-[(3S,5S,8R,9S,10S,13R,14S,15R,17R)-3-[tert-butyl(dimethyl)silyl]oxy-15-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]propyl] acetate
SMILESCC(=O)OC[C@H](C)[C@H]1C[C@@H](O)[C@H]2[C@@H]3CC[C@H]4C[C@@H](O[Si](C)(C)C(C)(C)C)CC[C@]4(C)[C@H]3CC[C@@]21C
InChIInChI=1S/C30H54O4Si/c1-19(18-33-20(2)31)25-17-26(32)27-23-11-10-21-16-22(34-35(8,9)28(3,4)5)12-14-29(21,6)24(23)13-15-30(25,27)7/h19,21-27,32H,10-18H2,1-9H3/t19-,21-,22-,23+,24-,25+,26+,27+,29-,30+/m0/s1
InChIKeyLQTACQUVWBJABA-NSAGRRLOSA-N
MW506.84 g/mol
LogP7.21
Rot. Bonds5

About [(2R)-2-[(3S,5S,8R,9S,10S,13R,14S,15R,17R)-3-[tert-butyl(dimethyl)silyl]oxy-15-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]propyl] acetate

[(2R)-2-[(3S,5S,8R,9S,10S,13R,14S,15R,17R)-3-[tert-butyl(dimethyl)silyl]oxy-15-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]propyl] acetate (PubChem CID 100995819) has the molecular formula C30H54O4Si and a molecular weight of 506.84 g/mol. Its IUPAC name is [(2R)-2-[(3S,5S,8R,9S,10S,13R,14S,15R,17R)-3-[tert-butyl(dimethyl)silyl]oxy-15-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]propyl] acetate.

Molecular Properties

Compound Name[(2R)-2-[(3S,5S,8R,9S,10S,13R,14S,15R,17R)-3-[tert-butyl(dimethyl)silyl]oxy-15-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]propyl] acetate
PubChem CID100995819
Molecular FormulaC30H54O4Si
Molecular Weight506.84 g/mol
Exact Mass506.38
IUPAC Name[(2R)-2-[(3S,5S,8R,9S,10S,13R,14S,15R,17R)-3-[tert-butyl(dimethyl)silyl]oxy-15-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]propyl] acetate
SMILESCC(=O)OC[C@H](C)[C@H]1C[C@@H](O)[C@H]2[C@@H]3CC[C@H]4C[C@@H](O[Si](C)(C)C(C)(C)C)CC[C@]4(C)[C@H]3CC[C@@]21C
InChIInChI=1S/C30H54O4Si/c1-19(18-33-20(2)31)25-17-26(32)27-23-11-10-21-16-22(34-35(8,9)28(3,4)5)12-14-29(21,6)24(23)13-15-30(25,27)7/h19,21-27,32H,10-18H2,1-9H3/t19-,21-,22-,23+,24-,25+,26+,27+,29-,30+/m0/s1
InChIKeyLQTACQUVWBJABA-NSAGRRLOSA-N
XLogP7.21
TPSA55.76 Ų
H-Bond Donors1
H-Bond Acceptors4
Rotatable Bonds5
Heavy Atoms35
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500506.84
LogP ≤ 57.21
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 104

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'heavy_metal', 'substructure': 'N/A'}

Analyze [(2R)-2-[(3S,5S,8R,9S,10S,13R,14S,15R,17R)-3-[tert-butyl(dimethyl)silyl]oxy-15-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]propyl] acetate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [(2R)-2-[(3S,5S,8R,9S,10S,13R,14S,15R,17R)-3-[tert-butyl(dimethyl)silyl]oxy-15-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]propyl] acetate?
The IUPAC name of [(2R)-2-[(3S,5S,8R,9S,10S,13R,14S,15R,17R)-3-[tert-butyl(dimethyl)silyl]oxy-15-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]propyl] acetate (CID 100995819) is [(2R)-2-[(3S,5S,8R,9S,10S,13R,14S,15R,17R)-3-[tert-butyl(dimethyl)silyl]oxy-15-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]propyl] acetate.
What is the SMILES notation for [(2R)-2-[(3S,5S,8R,9S,10S,13R,14S,15R,17R)-3-[tert-butyl(dimethyl)silyl]oxy-15-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]propyl] acetate?
The canonical SMILES for [(2R)-2-[(3S,5S,8R,9S,10S,13R,14S,15R,17R)-3-[tert-butyl(dimethyl)silyl]oxy-15-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]propyl] acetate is CC(=O)OC[C@H](C)[C@H]1C[C@@H](O)[C@H]2[C@@H]3CC[C@H]4C[C@@H](O[Si](C)(C)C(C)(C)C)CC[C@]4(C)[C@H]3CC[C@@]21C.
What is the InChIKey of [(2R)-2-[(3S,5S,8R,9S,10S,13R,14S,15R,17R)-3-[tert-butyl(dimethyl)silyl]oxy-15-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]propyl] acetate?
The InChIKey is LQTACQUVWBJABA-NSAGRRLOSA-N. The full InChI is InChI=1S/C30H54O4Si/c1-19(18-33-20(2)31)25-17-26(32)27-23-11-10-21-16-22(34-35(8,9)28(3,4)5)12-14-29(21,6)24(23)13-15-30(25,27)7/h19,21-27,32H,10-18H2,1-9H3/t19-,21-,22-,23+,24-,25+,26+,27+,29-,30+/m0/s1.
What are the key properties of [(2R)-2-[(3S,5S,8R,9S,10S,13R,14S,15R,17R)-3-[tert-butyl(dimethyl)silyl]oxy-15-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]propyl] acetate?
[(2R)-2-[(3S,5S,8R,9S,10S,13R,14S,15R,17R)-3-[tert-butyl(dimethyl)silyl]oxy-15-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]propyl] acetate has a molecular weight of 506.84 g/mol, XLogP of 7.21, 5 rotatable bonds, 1 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for [(2R)-2-[(3S,5S,8R,9S,10S,13R,14S,15R,17R)-3-[tert-butyl(dimethyl)silyl]oxy-15-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]propyl] acetate is sourced from PubChem (CID 100995819), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).